Prostate zones and cancer: lost in transition?

A Ali, A Du Feu, P Oliveira, A Choudhury… - Nature Reviews …, 2022 - nature.com
Localized prostate cancer shows great clinical, genetic and environmental heterogeneity;
however, prostate cancer treatment is currently guided solely by clinical staging, serum PSA …

[HTML][HTML] Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological …

F Kızılay, S Çelik, S Sözen, B Özveren, S Eskiçorapçı… - Prostate …, 2020 - Elsevier
Background Histopathological features after radical prostatectomy (RP) provide important
information for the prognosis of prostate cancer (PCa). The possible correlations between …

The tumor microenvironments of lethal prostate cancer

WL Harryman, NA Warfel, RB Nagle… - Prostate Cancer: Cellular …, 2019 - Springer
Localized prostate cancer (confined to the gland) generally is considered curable, with
nearly a 100% 5-year-survival rate. When the tumor escapes the prostate capsule, leading …

Artificial intelligence combined with big data to predict lymph node involvement in prostate cancer: a population-based study

L Wei, Y Huang, Z Chen, H Lei, X Qin, L Cui… - Frontiers in …, 2021 - frontiersin.org
Background A more accurate preoperative prediction of lymph node involvement (LNI) in
prostate cancer (PCa) would improve clinical treatment and follow-up strategies of this …

[HTML][HTML] Exploring the potential of ex-vivo 7-T magnetic resonance imaging on patients with clinically significant prostate cancer: visibility and size perspective

H Ahn, JK Kim, SI Hwang, SK Hong, SS Byun… - Prostate …, 2024 - Elsevier
Background Despite progress in multiparametric magnetic resonance imaging (MRI), issues
of prostate cancer invisibility and underestimated tumor burden persist. This study …

Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer

A Mahran, K Mishra, L Bukavina, F Schumacher… - … Urology and Nephrology, 2019 - Springer
Objective To evaluate the trend that despite recent advances in the screening, diagnosis,
and management of prostate cancer (PCa), African-Americans (AAs) continue to have …

[HTML][HTML] Mri-based cancer lesion analysis with 3d printed patient specific prostate cutting guides

DR Rutkowski, SA Wells, B Johnson… - American Journal of …, 2019 - ncbi.nlm.nih.gov
Purpose: MRI methods have improved diagnosis and treatment planning for prostate cancer.
However, validation and standardization is needed to encourage widespread adoption of …

[PDF][PDF] Methods for Prostate Cancer Risk Stratification: Serum-Based and Urine-Based Biomarkers for Biopsy Consideration

AS Bart, RDT Badre-Hume, ME Roberts… - Rev …, 2024 - articles-cdn.specialtynetworks.com
Abstract Background: Prostate cancer (PCa) is one of the most commonly occurring cancers
in men globally. In 2024, it is estimated that there will be 99 010 PCa diagnoses and 35 250 …

Targeting intra‐tumoral heterogeneity of human brain tumors with in vivo imaging: A roadmap for imaging genomics from multiparametric MR signals

JG Parker, M Servati, EE Diller, S Cao, C Ho… - Medical …, 2023 - Wiley Online Library
Resistance of high grade tumors to treatment involves cancer stem cell features,
deregulated cell division, acceleration of genomic errors, and emergence of cellular variants …

Integrating biomarkers and multi-parametric MRI to provide enhanced clinical diagnosis for prostate cancer

J Alter, DM Albala - Frontiers in Urology, 2023 - frontiersin.org
Prostate cancer (PCa) risk assessment can incorporate clinical features, gene expression,
protein 'biomarkers' or imaging. In this review the benefits of layering multiparametric …